|
26 Aug 2008 |
Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
|
|
21 Aug 2008 |
NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients
|
|
21 Aug 2008 |
VaxInnate's M2e Universal Influenza Vaccine Candidate Demonstrates Safety and Immunogenicity in Phase I Clinical Study
|
|
21 Aug 2008 |
VaxInnate's M2e Universal Influenza Vaccine Candidate Demonstrates Safety and Immunogenicity in Phase I Clinical Study
|
|
20 Aug 2008 |
BioVex Announces Regulatory Clearance to Commence a Clinical Study With ImmunoVEX HSV2; A Vaccine Candidate for Genital Herpes
|
|
19 Aug 2008 |
EndoBiologics, Incorporated, and PATH Form New Collaboration to Research Vaccine Candidates Against Diarrheal Disease
|
|
16 Aug 2008 |
Cytos Biotechnology and Pfizer enter into a research, option and license agreement for certain novel vaccines for a defined number of human diseases
|
|
14 Aug 2008 |
Bioms Medical Announces Positive Interim Analysis on Phase III Trial of Dirucotide (MBP8298) For Multiple Sclerosis
|
|
07 Aug 2008 |
DOR BioPharma Announces Initiation of Second Human Clinical Trial for RiVax(TM), Its Ricin Toxin Vaccine
|
|
06 Aug 2008 |
Dynavax and Merck & Co., Inc. Announce Phase 3 Trial with Investigational Hepatitis B Vaccine (HEPLISAV(TM)) Met its Primary Endpoint
|
|
05 Aug 2008 |
Bionor Immuno have started a Vacc-4x Phase IIB TOC study in US and Europe with enrollment of 345 patients.
|
|
03 Aug 2008 |
Bioms Medical Completes Patient Recruitment in Phase III U.S. Multiple Sclerosis Trial
|
|
28 Jul 2008 |
Nventa Announces Final Data From HSPE7 Phase I Cervical Dysplasia Trial
|
|
23 Jul 2008 |
Nabi Biopharmaceuticals Announces Positive Interim Results of NicVAX Immunogenicity Study
|
|
22 Jul 2008 |
Opexa Conducts Additional Analysis on Phase I/II Extension Study with Tovaxin(R) for Multiple Sclerosis
|
|
18 Jul 2008 |
Biovest Reports Results for Patients Treated with Anti-Cancer Vaccine: BiovaxID(R) Demonstrates Clinically and Statistically Significant Improvement of Disease-Free Survival in Non-Hodgkin's Lymphoma in Pivotal Phase 3 Clinical Trial
|
|
16 Jul 2008 |
AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer's Vaccine
|
|
13 Jul 2008 |
Oxford BioMedica Announces Data Safety Monitoring Board Reccomendation for TroVax(R) Phase III Trist Study
|
|
10 Jul 2008 |
CYT003-QbG10 monotherapy for the treatment of allergic diseases is safe and efficacious in placebo-controlled phase II study
|
|
10 Jul 2008 |
Investigational New Drug Application Submitted On Behalf of Generex Biotechnology for Combination Immunotherapy Vaccine Trials
|
|
08 Jul 2008 |
Opexa’s Phase IIb Study of Tovaxin(R) Receives Positive Review from Data Safety Monitoring Board
|
|
08 Jul 2008 |
Start of Phase I Study for Intranasal Pandemic Influenza Vaccine deltaFLU
|
|
01 Jul 2008 |
IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP)
|
|
30 Jun 2008 |
GlaxoSmithKline responds to FDA on Cervarix(R) and plans to submit final study data for approval
|
|
30 Jun 2008 |
Sinovac Initiates Phase II Volunteer Enrollment for Split Viron Pandemic Influenza (H5N1) Vaccine
|
